Pages that link to "Q58280584"
Jump to navigation
Jump to search
The following pages link to HPV infection in Europe (Q58280584):
Displaying 50 items.
- Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysis (Q33617489) (← links)
- Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy (Q33618543) (← links)
- Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia (Q33888215) (← links)
- Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia (Q34340212) (← links)
- Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany (Q34622565) (← links)
- Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students (Q35028233) (← links)
- Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance (Q35088687) (← links)
- Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions (Q35145756) (← links)
- Frequency of Human Papillumavirus among Women with High-Grade Squamous Intraepithelial Lesions and Invasive Cervical Cancer Attending Shahid Beheshti University of Medical Sciences Clinics, Tehran, Iran. (Q35666721) (← links)
- Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker (Q36183493) (← links)
- HPV prophylactic vaccination in males improves the clearance of semen infection (Q36252874) (← links)
- High-risk human papillomavirus infection in HIV-positive African women living in Europe (Q36614735) (← links)
- The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study (Q36699005) (← links)
- HPV infection in women with and without cervical cancer in Conakry, Guinea (Q37269638) (← links)
- Anal human papillomavirus genotype distribution in HIV-infected men who have sex with men by geographical origin, age, and cytological status in a Spanish cohort. (Q37470282) (← links)
- A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France (Q37521892) (← links)
- A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD. (Q37745678) (← links)
- Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (Q37802641) (← links)
- Monitoring of human papillomavirus vaccination. (Q37808256) (← links)
- Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance (Q37983132) (← links)
- Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe (Q38023288) (← links)
- Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas (Q38418221) (← links)
- Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy (Q38839112) (← links)
- Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study (Q38944257) (← links)
- Human papillomavirus infection in a population-based sample of women in Algiers, Algeria (Q39043655) (← links)
- What is the future burden of HPV-related cancers in Spain? (Q39399734) (← links)
- Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines (Q39599857) (← links)
- Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study (Q39629659) (← links)
- Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study (Q39687528) (← links)
- Enhancing intentions to attend cervical cancer screening with a stage-matched intervention (Q39794499) (← links)
- HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN. (Q40793088) (← links)
- Prevalence and genotype distribution of human papillomavirus infection in asymptomatic women in Liaoning province, China (Q41327630) (← links)
- High-risk human papillomavirus in Galicia, Spain: prevalence and evaluation of the sample representativeness. (Q41753413) (← links)
- Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein (Q42048699) (← links)
- Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening (Q42209186) (← links)
- Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program (Q42215194) (← links)
- Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy (Q42217974) (← links)
- Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand (Q42262387) (← links)
- Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol (Q42278781) (← links)
- Early detection of cervical cancer in Germany: evidence and implementation (Q43527960) (← links)
- Economic burden of HPV-related cancers in France (Q43603050) (← links)
- Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study (Q45215935) (← links)
- Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark (Q45353082) (← links)
- HPV infection in the oral cavity: epidemiology, clinical manifestations and relationship with oral cancer (Q47106612) (← links)
- Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base (Q47128634) (← links)
- New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis. (Q47353782) (← links)
- The prevalence of human papillomavirus in pediatric tonsils: a systematic review of the literature. (Q47645082) (← links)
- Trends in the incidence of oral cavity and oropharyngeal cancers in Spain. (Q51166439) (← links)
- Aggregation and competitive exclusion: explaining the coexistence of human Papillomavirus types and the effectiveness of limited vaccine conferred cross-immunity (Q51557810) (← links)
- Prevalence and distribution of human papillomavirus findings in swab specimens from gynaecology clinics of the east coast of Spain (Q51578981) (← links)